Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Bullboard Posts
Post by aebestaceyon Apr 17, 2018 9:08pm
264 Views
Post# 27901863

Interesting ............

Interesting ............


Until this week, the most important event for the cannabis industry was likely the Cole Memo that the Obama Administration issued in 2013. At that time, it was unclear how the federal government would handle the implementation of legal cannabis for adults in Colorado and Washington, which had both seen voters approve ballot initiatives in 2012.

The "hands-off" approach gave entrepreneurs and their investors a green light to proceed, and clearly the industry has flourished subsequently, with not only those states but also several others now regulating commercial cannabis. As we warned last year, though, the federal policy was only a guideline and not law, which many only appreciated better after Jeff Sessions ripped up the Cole Memo in early January.

A cloud of uncertainty has been hanging over our industry since the elections in late 2016, and, while we avoided a worst-case outcome with the recent extension of protections for medical cannabis during the budget process, investors and operators have been rightly concerned about the threat of push-back from the federal government.

This week, though, we got a very clear signal that a more permanent policy could be put in place, as Senator Cory Gardner of Colorado was able to apparently get the President on board. Gardner, the sole Republican senator among the states with the most to lose, including his own state as well as California, Oregon and Washington, joins several other members of Congress who have championed our cause, and hopefully this agreement comes to fruition.

The federal government is not likely to be legalizing cannabis. Instead, this potential legislation will create clear guidelines that set regulation at the state level and address important issues like taxation, research, access by veterans and banking. It may take quite some time to be finalized, but we think that the potential for a shift in federal policy will trigger an immediate wave of capital formation as investors sense the likely erosion of risk, and we point to Canada as an example.

While 2 1/2 years after Justin Trudeau won the nation still hasn't finalized its program, with implementation expected in the late summer after a final vote in early June, investors have poured large amounts of capital into the industry. We see a wave of investment ahead now in the United States, as investors sense a better reward-to-risk ratio as federal policy becomes clearer.

Cannabis stocks jumped sharply on Friday, and we won't be surprised to see this trend persist. In fact, we point to prices still substantially lower than in early January, when Sessions dumped ice water on the rally inspired by California legalizing. Beyond healthy equity markets, we expect private investors are going to be more open to backing cannabis and cannabis-related companies.

Are already seeing more established companies like Acreage Holdings and Medmen eyeing the public markets, and we expect that a more robust public market will give investors in private companies more confidence that they have a potential exit strategy. 

The bottom-line is that this week's news, while certainly not yet final, is a potentially powerful catalyst that could allow our industry to accelerate its growth quite dramatically. 
 
 
 


Bullboard Posts